Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v3.23.3
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The tables below present financial information for the Company’s two operating business segments.
Three Months Ended
March 31,
2023 2022
Revenues:
(as restated)
Corporate clinics $ 17,127,957  $ 12,606,999 
Franchise operations 11,172,863  9,629,752 
Total revenues $ 28,300,820  $ 22,236,751 
Depreciation and amortization:
Corporate clinics 1,927,091  1,083,676 
Franchise operations 198,974  173,487 
Corporate administration 88,990  79,493 
Total depreciation and amortization $ 2,215,055  $ 1,336,656 
Segment operating (loss) income:
Corporate clinics $ (422,053) $ (145,544)
Franchise operations 4,541,899  4,248,435 
Total segment operating income $ 4,119,846  $ 4,102,891 
Reconciliation of total segment operating income to consolidated earnings before income taxes:
Total segment operating income $ 4,119,846  $ 4,102,891 
Unallocated corporate (4,772,955) (4,141,600)
Consolidated (loss) from operations (653,109) (38,709)
Other income (expense), net 3,821,162  (16,147)
(Loss) income before income tax benefit $ 3,168,053  $ (54,856)
Schedule of Reconciliation of Assets from Segment to Consolidated
March 31,
2023
December 31,
2022
Segment assets:
(as restated)
Corporate clinics $ 57,207,324  $ 56,008,234 
Franchise operations 12,855,697 12,360,878
Total segment assets 70,063,021 68,369,112
Unallocated cash and cash equivalents and restricted cash 15,504,604 10,550,417
Unallocated property and equipment 566,513 915,216
Other unallocated assets 13,488,907 13,655,632
Total assets $ 99,623,045  $ 93,490,377